Katie Patel

Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers

Navita L. Mallalieu, Erica Winter, Scott Fettner et al. · Antimicrobial Agents and Chemotherapy · 2020 · 63 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Increases in Hip and Spine Bone Mineral Density are Predictive for Vertebral Antifracture Efficacy with Ibandronate

Paul D. Miller, Pierre D. Delmas, Hermann Huss et al. · Calcified Tissue International · 2010 · 30 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +14

Use of a historical control group in a noninferiority trial assessing a new antibacterial treatment: A case study and discussion of practical implementation aspects

David Dejardin, Paul Delmar, Charles Warne et al. · Pharmaceutical Statistics · 2017 · 28 citations

Medicine, Biostatistics, Clinical Epidemiology +12

2126. Safety, Tolerability, and Pharmacokinetics (PK) in Healthy Participants Following Single Dose Administration of Zosurabalpin, a Novel Pathogen-Specific Antibiotic for the Treatment of Serious <i>Acinetobacter</i> Infections

Andreas Guenther, Laurie Millar, Amanda Messer et al. · Open Forum Infectious Diseases · 2023 · 17 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Intraretinal Hyper-Reflective Foci Are Almost Universally Present and Co-Localize With Intraretinal Fluid in Diabetic Macular Edema

Esther L. von Schulthess, Andreas Maunz, Usha Chakravarthy et al. · Investigative Ophthalmology & Visual Science · 2024 · 15 citations · Full text

Health Professions, Ophthalmology, Vision Science +17